These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 21570128

  • 21. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study.
    Daniel DG, Goldberg TE, Weinberger DR, Kleinman JE, Pickar D, Lubick LJ, Williams TS.
    Am J Psychiatry; 1996 Mar; 153(3):417-9. PubMed ID: 8610833
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis.
    Khalil H, Hoppe D, Ameen N.
    Ther Adv Drug Saf; 2021 Mar; 12():20420986211012854. PubMed ID: 34104400
    [Abstract] [Full Text] [Related]

  • 23. Atypical Antipsychotics and Relapsing Psychoses in 22q11.2 Deletion Syndrome: A Long-term Evaluation of 28 Patients.
    Verhoeven WM, Egger JI.
    Pharmacopsychiatry; 2015 May; 48(3):104-10. PubMed ID: 25654302
    [Abstract] [Full Text] [Related]

  • 24. Modern antipsychotic drugs: a critical overview.
    Gardner DM, Baldessarini RJ, Waraich P.
    CMAJ; 2005 Jun 21; 172(13):1703-11. PubMed ID: 15967975
    [Abstract] [Full Text] [Related]

  • 25. [Difficulties in the treatment of psychosis in young patients with epilepsy].
    Johansson BA, Jarbin H, Lundgren J.
    Lakartidningen; 2001 Dec 05; 98(49):5661-4. PubMed ID: 11783054
    [Abstract] [Full Text] [Related]

  • 26. Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antipsychotic Medications Palliate Symptoms in Children with Cancer.
    Peled O, Lavan O, Stein J, Vinograd I, Yahel A, Valevski A, Weizman A, Kimmel-Tamir E, Apter A, Fennig S, Yaniv I, Bernfeld Y, Benaroya-Milshtein N.
    J Child Adolesc Psychopharmacol; 2020 Oct 05; 30(8):486-494. PubMed ID: 32845729
    [Abstract] [Full Text] [Related]

  • 27. Recent developments in the management of psychosis.
    Hoes MJ.
    Pharm World Sci; 1998 Jun 05; 20(3):101-6. PubMed ID: 9618732
    [Abstract] [Full Text] [Related]

  • 28. Use of antipsychotic agents in Spain through 1985-2000.
    Santamaría B, Pérez M, Montero D, Madurga M, de Abajo FJ.
    Eur Psychiatry; 2002 Dec 05; 17(8):471-6. PubMed ID: 12504264
    [Abstract] [Full Text] [Related]

  • 29. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
    Ravanic DB, Dejanovic SM, Janjic V, Jovic SD, Milovanovic DR, Jakovljevic V, Pantovic V, Ravanic B, Pantovic M, Pantovic MM.
    Arq Neuropsiquiatr; 2009 Jun 05; 67(2A):195-202. PubMed ID: 19547808
    [Abstract] [Full Text] [Related]

  • 30. [Not Available].
    Angelopoulos E, Theleritis C, Economou M, Georgatou K, Papageorgiou CC, Tsaltas E.
    Pharmacopsychiatry; 2017 Jul 05; 50(4):162-163. PubMed ID: 28511206
    [Abstract] [Full Text] [Related]

  • 31. Clozapine as a mood stabiliser for schizoaffective disorder: Effectiveness during a three-month follow-up.
    Peraire M, Arnau-Peiró F, Benito A, Fuertes-Saiz A, Almodóvar-Fernández I, Haro G.
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Dec 20; 135():111090. PubMed ID: 39019430
    [Abstract] [Full Text] [Related]

  • 32. Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.
    Grohmann R, Engel RR, Möller HJ, Rüther E, van der Velden JW, Stübner S.
    Eur Arch Psychiatry Clin Neurosci; 2014 Mar 20; 264(2):131-41. PubMed ID: 23835526
    [Abstract] [Full Text] [Related]

  • 33. Risk of New-Onset Diabetes After Long-Term Treatment With Clozapine in Comparison to Other Antipsychotics in Patients With Schizophrenia.
    Schulte PF, Bocxe JT, Doodeman HJ, van Haelst IM, Cohen D.
    J Clin Psychopharmacol; 2016 Apr 20; 36(2):115-9. PubMed ID: 26872114
    [Abstract] [Full Text] [Related]

  • 34. Men and women respond differently to antipsychotic drugs.
    Seeman MV.
    Neuropharmacology; 2020 Feb 20; 163():107631. PubMed ID: 31077728
    [Abstract] [Full Text] [Related]

  • 35. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.
    Wilson RP, Bhattacharyya S.
    J Psychopharmacol; 2016 Feb 20; 30(2):99-111. PubMed ID: 26510450
    [Abstract] [Full Text] [Related]

  • 36. Paediatric uses of atypical antipsychotics.
    Findling RL, McNamara NK, Gracious BL.
    Expert Opin Pharmacother; 2000 Jul 20; 1(5):935-45. PubMed ID: 11249501
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia.
    Wardenier M, Slooff CJ, Arends J.
    Acta Neuropsychiatr; 2000 Dec 20; 12(4):183-92. PubMed ID: 26975433
    [Abstract] [Full Text] [Related]

  • 38. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.
    Schimmelmann BG, Paulus S, Schacht M, Tilgner C, Schulte-Markwort M, Lambert M.
    J Child Adolesc Psychopharmacol; 2005 Apr 20; 15(2):249-58. PubMed ID: 15910209
    [Abstract] [Full Text] [Related]

  • 39. Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male.
    Kutlu A, Songür ÇY, Apa H.
    Arch Iran Med; 2023 Jan 01; 26(1):50-53. PubMed ID: 37543922
    [Abstract] [Full Text] [Related]

  • 40. Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital.
    Oh S, Lee TY, Kim M, Kim SH, Lee S, Cho S, Kim JH, Kwon JS.
    NPJ Schizophr; 2020 Nov 19; 6(1):32. PubMed ID: 33214559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.